The Global War on Repurposed Drugs, a European Perspective: FLCCC Weekly Update (June 08, 2022)

1 year ago
37

This week two brilliant guests, Dr. Andrea Stramezzi from Italy and Dr. Thomas Binder from Switzerland, joined Dr. Pierre Kory and Dr. Paul Marik to discuss Europe's reaction to the use of repurposed drugs.

Dr. Stramezzi has treated over 5,000 COVID patients, never charging a penny, because he felt that it was his duty as a doctor in an emergency to help. For this, he was arrested by Italian Military Police and suspended for 12 months for not practicing according to the Italian Ministry of Health Guidelines.

Dr. Binder realized the whole prevailing Corona narrative was "unscientific nonsense." He wrote a blog explaining this just before Easter 2020. It was clicked 20,000 times. Then, on Easter Saturday at 10pm, he was brutally arrested by a Swiss anti-terrorist unit, having been denounced by two well-known acquaintances who felt threatened by his writings. Watch the video to see what happened after that.

Also, don't miss updates from Dr. Marik on the new I-RECOVER: Post-Vaccine Treatment Protocol.

------------------------------------------

Formed by leading critical care specialists in March 2020, the Front Line COVID-19 Critical Care Alliance (FLCCC) has developed highly effective treatment protocols that aim to prevent and treat COVID-19 at all stages of the disease.

We are a 100% donor-supported 501(c)(3) non-profit organization — our work would not be possible without you.
Your gifts help us expand our reach and share the latest research available, for the health and well-being of all.

To donate online, click here: https://covid19criticalcare.com/network-support/support-our-work/

To follow FLCCC, click here: https://covid19criticalcare.com/follow-flccc-2/

To learn more about our protocols click here https://covid19criticalcare.com/covid-19-protocols/

To register for weekly webinars, click here: https://geni.us/FLCCC_Webinar_Register

To buy FLCCC gear, click here: https://supportflccc.store/

Content Managed by ContentSafe.co

Loading comments...